BioPharm International
CONTINUE TO SITE

OR WAIT null SECS

Advertisement
BioPharm International
Spotlight
COVID-19 UpdateAnalyticsDevelopmentDownstream ProcessingManufacturingOutsourcingQuality/GMPsUpstream Processing
Topic
View MoreAnalytical MethodsBioBusinessCell Culture/FermentationContinuous ProcessingDrug DeliveryFill/FinishFormulationProcess ChromatographyProcess Control/PATProcess DevelopmentQA/QCSeparation and PurificationSingle-Use SystemsSupply Chain
News
All NewsTop NewsBio/Pharma NewsIndustry NewsSupplier NewsEvents
Publications
All PublicationsBioPharm International
Resources
Podcast SeriesBiopharma InsightsSponsored eBooksSponsored PodcastsSponsored VideosWhitepapers
Webcasts
Subscribe
EnewsMagazine

  • About Us
  • Advertise
  • Editorial Information
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
  • MJHLS Brand Logo

© 2023 MJH Life Sciences and BioPharm International. All rights reserved.

Spotlight
  • COVID-19 Update
  • Analytics
  • Development
  • Downstream Processing
  • Manufacturing
  • Outsourcing
  • Quality/GMPs
  • Upstream Processing
TopicSee All >
  • Analytical Methods
  • BioBusiness
  • Cell Culture/Fermentation
  • Continuous Processing
  • Drug Delivery
  • Fill/Finish
  • Formulation
  • Process Chromatography
  • Process Control/PAT
  • Process Development
  • QA/QC
  • Separation and Purification
  • Single-Use Systems
  • Supply Chain
  • About Us
  • Advertise
  • Editorial Information
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.

Featured Content

Six Approaches Making the Most Significant Impact in the Future

Six Approaches Making the Most Significant Impact in the Future

This compilation allows readers to adjust their thinking to appreciate the full impact certain select technologies will make on the industry by 2026.

Purification of Antibodies Using Novel Convecdiff Membranes Part 1

Purification of Antibodies Using Novel Convecdiff Membranes Part 1

The testing of new convecdiff membranes shows this material to be well suited for lab- and commercial-scale bind-and-elute applications.

Crossing the Same River Multiple Times

Crossing the Same River Multiple Times

Cautiously setting aside pandemic practices, pharma workers appear ready for flux, change, evolution, and expanding molecular diversity.

Complex Analytical Workflows Increasingly Require Robust Bioassays

Complex Analytical Workflows Increasingly Require Robust Bioassays

Biologic drug development requires relevant bioassays to measure and help predict cellular response.

Choosing the Right Resins for Viral Vector Affinity Chromatography

Choosing the Right Resins for Viral Vector Affinity Chromatography

Affinity chromatography resins must perform well under mild elution conditions yet withstand robust cleaning and sanitization protocols.

Safeguarding Biologics— Blending Engineering Ingenuity and Managerial Excellence

Safeguarding Biologics— Blending Engineering Ingenuity and Managerial Excellence

Efforts to optimize the ideal blend of technology and best practices that are needed to protect and deliver time- and temperature-sensitive biologic therapies, vaccines, and cell and gene therapies continue to evolve.

Pandemic and Politics Shaped Pharma and FDA in 2022

Pandemic and Politics Shaped Pharma and FDA in 2022

Health crises, political tension, and budget concerns were major challenges.